Microbial and protozoal DNA (DNA)

Microbial and protozoal DNA serves as the fundamental repository of genetic information required for the growth, survival, and reproduction of bacteria and eukaryotic parasites (StatPearls, 2023). In pharmacology, this DNA is a critical therapeutic target for several classes of antimicrobial and antiprotozoal agents, most notably the nitroimidazoles like metronidazole and tinidazole (PubChem, CID 4173). These drugs typically act as prodrugs that are selectively activated within anaerobic or microaerophilic environments to form highly reactive nitro-radical intermediates. These intermediates interact directly with the DNA helical structure, causing oxidative damage and covalent binding that results in DNA strand breakage (PubMed, PMID 15888526). This disruption effectively halts DNA synthesis and leads to rapid cell death in pathogens such as Trichomonas vaginalis, Giardia lamblia, and various anaerobic bacteria. Because the activation of these drugs often requires specific electron transport proteins like ferredoxin found in these microbes, the target offers a degree of selectivity, although potential mutagenic effects on host DNA and the development of resistance remain significant therapeutic challenges (NIH, 2022).

Other names

Bacterial DNAProtozoan DNAPathogen genomic DNAMicrobial genome

Reduction of nitro groups by microbial enzymes (like ferredoxin-oxidoreductase) to form reactive nitro-radical intermediates that cause covalent binding to DNA, oxidative damage, and double-strand breaks, leading to the inhibition of nucleic acid synthesis and cell death (StatPearls, 2023; PubMed, PMID 10348344).